Calcium hydroxylapatite is a widely used dermal semi-permanent wrinkle filler used in several dermatological applications in conditions such as face folds and replenish lost facial volume. Calcium hydroxylapatite is an atheistic medicine used for facial soft tissue augmentation. Calcium hydroxylapatite is associated with high safety profile and has high elasticity and viscosity, which leads to long term collagen formation. Calcium hydroxylapatite has physical characteristics such as viscosity, elasticity, and cohesivity. Calcium hydroxylapatite is administered intravenously with blunt tip micro-cannula.
Global Calcium Hydroxylapatite (CaHA) Fillers Market - Drivers
Calcium hydroxylapatite (CaHA) fillers market is expected to exhibit high growth, owing to rising awareness about self-appearance and cosmetic procedures, and increasing number of dermatological consultancy and dermatology clinics. Moreover, patients are comfortable with dermal filler procedure due to less pain in treatment procedures. These factors are expected to drive the global calcium hydroxylapatite (CAHA) fillers market growth.
Global Calcium Hydroxylapatite (CaHA) Fillers Market - COVID-19 Impact Analysis
Since the outbreak of COVID-19 pandemic, each and every market across the world has been affected in a negative way. In the case of global calcium hydroxylapatite (CAHA) fillers market, imposed safety precautions to avoid spread of COVID-19 infection has led to complications in carrying out surgical treatments in dermatology. Moreover, patients with dermatological issues have scheduled appointments with clinics for regular checking. However, due to this pandemic, clinics have reduced the number of appointments and moved to only vulnerable patients.
Global Calcium Hydroxylapatite (CaHA) Fillers Market - Restraints
Inter-arterial injection of calcium hydroxylapatite filler includes serious complications such as soft tissue necrosis, permanent scarring, visual impairment, and blindness. Moreover, cost of calcium hydroxylapatite is US$ 650 to 800 per syringe, which is unaffordable for people in middle and low economic countries. These factors are expected to restrain the global calcium hydroxylapatite (CAHA) fillers market growth.
Global Calcium Hydroxylapatite (CaHA) Fillers Market - Regional Analysis
On the basis of region, the global calcium hydroxylapatite (CAHA) fillers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, pharmaceutical companies are focusing on research and development in the field of dermal fillers, thereby strengthening their market position in the global calcium hydroxylapatite (CAHA) fillers market. For instance, in 2016, RegenScientific, a subsidiary of Cytophill Inc, launched CE-marked Renú soft tissue volumizing filler at the International Masters Course on Aging Science (IMCAS) World Congress 2016.
Europe is expected to exhibit significant growth in the global calcium hydroxylapatite (CAHA) fillers market, as pharmaceutical companies are focusing on research and development in the field of dermal fillers, thereby strengthening their market position in the global calcium hydroxylapatite (CAHA) fillers market. For instance, in 2016, Merz Pharma GmbH & Co. KGaA received CE mark for Radiesse with integral 0.3% Lidocaine used for natural production of collagen to replenish lost facial volume.
Global Calcium Hydroxylapatite (CaHA) Fillers Market – Competitive Landscape
Key players operating in the global calcium hydroxylapatite (CAHA) fillers market include Regan Scientific Instruments, Inc, Allergan plc, Galderma Laboratories, L.P, Merz Pharma GmbH & Co. KGaA, Cynosure Inc, Prollenium Medical Technologies, Inc, Dr. Korman Laboratories Ltd, Luminera , CG Bio Co., Ltd, Medyglobal, and Teoxane SA.
Market Taxonomy
On the basis of strength, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:
On the basis of application, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:
On the basis of region, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:
Share
About Author
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients